Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50EV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenuePricePrice to Earnings
Growth Metrics
Income Statement
Others
Ratios

Kalaris Therapeutics (KLRS) EV to EBITDA (2025 - 2026)